Organon Q2 2024 Adj. EPS $1.12 Beats $1.08 Estimate, Sales $1.607B Miss $1.631B Estimate
Portfolio Pulse from Benzinga Newsdesk
Organon reported its Q2 2024 financial results with an adjusted EPS of $1.12, beating the estimate of $1.08. However, its sales of $1.607 billion missed the estimate of $1.631 billion.
August 06, 2024 | 11:31 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Organon reported an adjusted EPS of $1.12 for Q2 2024, beating the estimate of $1.08. However, its sales of $1.607 billion missed the estimate of $1.631 billion.
The mixed results, with EPS beating expectations but sales missing, are likely to have a neutral short-term impact on Organon's stock price. Investors may be encouraged by the EPS beat but concerned about the sales miss.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100